Immunosenescence and inflamm-ageing in COVID-19

Copyright © 2022 Elsevier B.V. All rights reserved..

The destructive effects of coronavirus disease 2019 (COVID-19) on the elderly and people with cardiovascular disease have been proven. New findings shed light on the role of aging pathways on life span and health age. New therapies that focus on aging-related pathways may positively impact the treatment of this acute respiratory infection. Using new therapies that boost the level of the immune system can support the elderly with co-morbidities against the acute form of COVID-19. This article discusses the effect of the aging immune system against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the pathways affecting this severity of infection.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:84

Enthalten in:

Ageing research reviews - 84(2023) vom: 25. Feb., Seite 101818

Sprache:

Englisch

Beteiligte Personen:

Zinatizadeh, Mohammad Reza [VerfasserIn]
Zarandi, Peyman Kheirandish [VerfasserIn]
Ghiasi, Mohsen [VerfasserIn]
Kooshki, Hamid [VerfasserIn]
Mohammadi, Mozafar [VerfasserIn]
Amani, Jafar [VerfasserIn]
Rezaei, Nima [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Immunosenescence
Inflamm-ageing
Journal Article
Review
SARS-CoV-2

Anmerkungen:

Date Completed 10.01.2023

Date Revised 25.02.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.arr.2022.101818

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM350288984